Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 2/20 | 0.58 |
| ▸ | PARP14 | Q460N5 | 3/20 | 0.52 |
| ▸ | KIF11 | P52732 | 4/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | MPL | P40238 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KLK7 | P49862 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3910030 | 1.00 | PBRM1 (0.58) | PBRM1PARP14KIF11AKR1C3MPL | |
| SCHEMBL6887283 | 0.95 | PBRM1 (0.55) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL27623354 | 0.92 | PBRM1 (0.53) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL1515615 | 0.90 | PBRM1 (0.54) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL4654498 | 0.90 | PBRM1 (0.60) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL11456236 | 0.89 | LIG1 (0.51) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL6887279 | 0.88 | PBRM1 (0.58) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL27695927 | 0.88 | PARP14 (0.61) | PBRM1PARP14 | |
| SCHEMBL28161975 | 0.88 | PBRM1 (0.49) | PBRM1PARP14KIF11MPLMAPT | |
| SCHEMBL28016957 | 0.88 | PBRM1 (0.49) | PBRM1PARP14KIF11MPLMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250376606-A1 | COMPOUND, ADDITIVE, PLASTICIZER, CURABLE COMPOSITION, ADHESIVE, CURED PRODUCT, AND PRESSURE-SENSITIVE ADHESIVE | MITSUI CHEMICALS INC (JP) | 2025-12-11 | — | — | US | disclosed |
| EP-4545514-A1 | COMPOUND, ADDITIVE, PLASTICIZER, CURABLE COMPOSITION, ADHESIVE, CURED PRODUCT AND TACKIFIER | Mitsui Chemicals, Inc. (JP) | 2025-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250376606-A1 | COMPOUND, ADDITIVE, PLASTICIZER, CURABLE COMPOSITION, ADHESIVE, CURED PRODUCT, AND PRESSURE-SENSITIVE ADHESIVE | COL1A1, COL2A1, COL14A1 | PBRM1 504/4885PARP14 3024/4885KIF11 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.